This Article Full Text Full Text (PDF) All Versions of this Article: 36/6/1316    most recent 01.STR.0000165929.78756.edv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Di Napoli, M. Articles by Weber, D. Search for Related Content PubMed PubMed Citation Articles by Di Napoli, M. Articles by Weber, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID Medline Plus Health Information Stroke Related Collections AHA Statements and Guidelines Other diagnostic testing Acute Cerebral Infarction

(Stroke. 2005;36:1316.)
© 2005 American Heart Association, Inc.

Special Report

Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke

A Statement for Health Care Professionals From the CRP Pooling Project Members

Mario Di Napoli, MD; Markus Schwaninger, MD; Roberto Cappelli, MD; Elena Ceccarelli, MD; Giacinto Di Gianfilippo, MD; Cristina Donati, MD; Hedley C.A. Emsley, PhD, MRCP; Sandro Forconi, MD; Stephen J. Hopkins, PhD; Luca Masotti, MD; Keith W. Muir, MD, FRCP; Anna Paciucci, MD; Francesca Papa, MD; Sabina Roncacci, MD; Dirk Sander, MD; Kerstin Sander, MD; Craig J. Smith, MD, MRCP; Alessandro Stefanini, MD Daniela Weber, MD

From the Neurological Service (M.D.N., G.D.G., A.P., S.R., A.S.), San Camillo de Lellis General Hospital, Rieti, Italy; Neurologische Klinik (M.S., DW.), University of Heidelberg, Heidelberg, Germany; the Department of Internal (R.C., E.C., C.D., S.F.), Cardiovascular, and Geriatric Medicine, University of Siena, Siena, Italy; Division of Neuroscience (H.C.A.E.), University of Liverpool, The Walton Centre for Neurology & Neurosurgery, Liverpool, UK; Injury Research (S.J.H.), University of Manchester and Hope Hospital, Salford, UK; Internal Medicine (L.M.), Cecina Hospital, Cecina, Livorno, Italy; the Division of Clinical Neurosciences (K.W.M.), University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland, UK; SMDN–Center for Cardiovascular Medicine and Cerebrovascular Disease Prevention (F.P.), Sulmona, L’Aquila, Italy; the Department of Neurology (D.S., K.S.), Technical University of Munich, Munich, Germany; and the Division of Medicine and Neurosciences-Hope (C.J.S.), University of Manchester, Hope Hospital, Salford, UK.

Correspondence to Mario Di Napoli, MD, Neurological Section, SMDN–Center for Cardiovascular Medicine and Cerebrovascular Disease Prevention, Via Trento, 41, 67039-Sulmona, L’Aquila, Italy. E-mail mariodinapoli{at}katamail.com

Background and Purpose— Several studies have shown, in different populations, that modest elevation of plasma C-reactive protein (CRP) in the range seen in apparently healthy individuals is a strong predictor of future vascular events. Elevated plasma CRP concentrations are also associated with an increased risk of cerebrovascular events and an increased risk of fatal and nonfatal cardiovascular events in ischemic stroke patients. These epidemiological and clinical observations suggest that determination of plasma CRP concentrations could be used as an adjunct for risk assessment in primary and secondary prevention of cerebrovascular disease and be of prognostic value. The aim of this review is to summarize the evidence for CRP as an independent predictor of cerebrovascular events in at-risk individuals and ischemic stroke patients and to consider its usefulness in evaluating prognosis after stroke.

Summary of Review— CRP fulfils most of the requirements of a new risk and prognostic predictor, but several issues await further confirmation and clarification before this marker can be included in the routine evaluation of stroke patients and subjects at risk for cerebrovascular disease. Potentially important associations have been established between elevated plasma CRP concentrations and increased efficacy of established therapies, particularly lipid-lowering therapy with statins.

Conclusion— At present, there is not sufficient evidence to recommend measurement of CRP in the routine evaluation of cerebrovascular disease risk in primary prevention, because there is insufficient evidence as to whether early detection, or intervention based on detection, improves health outcomes, although shared risk of cardiovascular disease indicates this may be of value. In secondary prevention of stroke, elevated CRP adds to existing prognostic markers, but it remains to be established whether specific therapeutic options can be derived from this.

Key Words: aspirin • cerebrovascular disorders • inflammation • meta-analysis • mortality • prevention • risk factors • scientific statements

This article has been cited by other articles:

				M. S. V. Elkind, P. Ramakrishnan, Y. P. Moon, B. Boden-Albala, K. M. Liu, S. L. Spitalnik, T. Rundek, R. L. Sacco, and M. C. Paik Infectious Burden and Risk of Stroke: The Northern Manhattan Study Arch Neurol, November 9, 2009; (2009) 2009.271. [Abstract] [Full Text] [PDF]

				M. Khatri, T. Nickolas, Y. P. Moon, M. C. Paik, T. Rundek, M. S. V. Elkind, R. L. Sacco, and C. B. Wright CKD Associates with Cognitive Decline J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2427 - 2432. [Abstract] [Full Text] [PDF]

				M.S.V. Elkind, J. M. Luna, Y. P. Moon, K. M. Liu, S. L. Spitalnik, M. C. Paik, and R. L. Sacco High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study Neurology, October 20, 2009; 73(16): 1300 - 1307. [Abstract] [Full Text] [PDF]

				D. A. Sbarra Marriage Protects Men from Clinically Meaningful Elevations in C-Reactive Protein: Results from the National Social Life, Health, and Aging Project (NSHAP) Psychosom Med, October 1, 2009; 71(8): 828 - 835. [Abstract] [Full Text] [PDF]

				M. S.V. Elkind, V. Leon, Y. P. Moon, M. C. Paik, and R. L. Sacco High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 Stability Before and After Stroke and Myocardial Infarction Stroke, October 1, 2009; 40(10): 3233 - 3237. [Abstract] [Full Text] [PDF]

				A. Meaney, G. Ceballos, J. Asbun, G. Solache, E. Mendoza, A. Vela, and E. Meaney The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study J. Clin. Pharmacol., July 1, 2009; 49(7): 838 - 847. [Abstract] [Full Text] [PDF]

				B. L. Cucchiara, S. R. Messe, L. Sansing, L. MacKenzie, R. A. Taylor, J. Pacelli, Q. Shah, and S. E. Kasner Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Risk-Stratification of Patients With TIA Stroke, July 1, 2009; 40(7): 2332 - 2336. [Abstract] [Full Text] [PDF]

				A. L. Hogh, J. Joensen, J. S. Lindholt, M. R. Jacobsen, and L. Ostergaard C-Reactive Protein Predicts Future Arterial and Cardiovascular Events in Patients With Symptomatic Peripheral Arterial Disease Vascular and Endovascular Surgery, August 1, 2008; 42(4): 341 - 347. [Abstract] [PDF]

				P. Welsh, G. D.O. Lowe, J. Chalmers, D. J. Campbell, A. Rumley, B. C. Neal, S. W. MacMahon, and M. Woodward Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke Stroke, August 1, 2008; 39(8): 2226 - 2230. [Abstract] [Full Text] [PDF]

				L. Masotti and R. Cappelli C-Reactive Protein in Elderly Patients With Suspected and Confirmed Pulmonary Embolism Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 221 - 223. [PDF]

				G Gromadzka, I Sarzynska-Dlugosz, and A Czlonkowska IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 183 - 186. [Abstract] [Full Text] [PDF]

				M. S. V. Elkind, W. Tai, K. Coates, M. C. Paik, and R. L. Sacco High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med, October 23, 2006; 166(19): 2073 - 2080. [Abstract] [Full Text] [PDF]

				G. P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, and S. Vigili de Kreutzenberg Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population Stroke, September 1, 2006; 37(9): 2277 - 2282. [Abstract] [Full Text] [PDF]

				C. Ladenvall, K. Jood, C. Blomstrand, S. Nilsson, C. Jern, and P. Ladenvall Serum C-Reactive Protein Concentration and Genotype in Relation to Ischemic Stroke Subtype Stroke, August 1, 2006; 37(8): 2018 - 2023. [Abstract] [Full Text] [PDF]

				D. Tanne, M. Benderly, U. Goldbourt, M. Haim, A. Tenenbaum, E. Z. Fisman, Z. Matas, Y. Adler, R. Zimmlichman, and S. Behar C-Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease Stroke, July 1, 2006; 37(7): 1720 - 1724. [Abstract] [Full Text] [PDF]